ERCC5 anticorps (N-Term)
Aperçu rapide pour ERCC5 anticorps (N-Term) (ABIN631899)
Antigène
Voir toutes ERCC5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- ERCC5 antibody was raised against the N terminal of ERCC5
-
Purification
- Affinity purified
-
Immunogène
- ERCC5 antibody was raised using the N terminal of ERCC5 corresponding to a region with amino acids NPQAIDIESEDFSSLPPEVKHEILTDMKEFTKRRRTLFEAMPEESDDFSQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ERCC5 Blocking Peptide, (ABIN5613393), is also available for use as a blocking control in assays to test for specificity of this ERCC5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ERCC5 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ERCC5 (DNA Repair Protein Complementing XP-G Cells (ERCC5))
-
Autre désignation
- ERCC5
-
Sujet
- Excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G) is involved in excision repair of UV-induced DNA damage. Mutations cause Cockayne syndrome, which is characterized by severe growth defects, mental retardation, and cachexia. Excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G) is involved in excision repair of UV-induced DNA damage.
-
Poids moléculaire
- 133 kDa (MW of target protein)
-
Pathways
- Réparation de l'ADN
Antigène
-